Company intelligence / Profile preview
Bio-Gels Pharmaceuticals
- Ownership
- Private
- Development stage
- Other
01
Overview
Bio-Gels Pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of advanced topical drug delivery systems. The company utilizes its proprietary Bio-Gel technology to enhance the penetration and efficacy of active pharmaceutical ingredients through the skin. Their product portfolio primarily addresses needs in pain management and wound care, offering alternatives to systemic treatments. By leveraging hydrogel-based formulations, Bio-Gels aims to provide sustained-release therapeutic benefits with reduced side effects.
- Therapeutic areas
- DermatologyNeurology
- Modalities
- Hydrogel-based drug delivery therapySmall molecule
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Bio-Gels Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bio-Gels Pharmaceuticals.